NEW YORK, NY, June 9, 2022. The Lupus Research Alliance (LRA), the world’s leading private funder of lupus research, today announced inaugural recipients of Career Development and Postdoctoral Awards to Promote Diversity in Lupus Research. The Diversity in Lupus Research Award funding mechanisms aim to address underrepresentation of minorities in the scientific research profession. Lupus […] READ MORE
June 2, 2022 The Lupus Research Alliance (LRA) and its clinical trial arm Lupus Therapeutics congratulate Bristol Myers Squibb (BMS) on new positive results presented at the European Alliance of Associations for Rheumatology (EULAR) 2022 Congress from a Phase 2 trial of its investigational biologic deucravacitinib for the treatment of systemic lupus erythematosus (SLE). Deucravacitinib […] READ MORE
May 25, 2022 In recognition of Asian American Pacific Islander Heritage Month, we spoke with the Program Supervisor of LANtern® (Lupus Asian Network) at the Hospital for Special Surgery to learn more about how lupus affects this population and what services are offered to the community. The Lupus Research Alliance collaborates closely with LANtern – […] READ MORE
May 14, 2022 EAST RUTHERFORD, NEW JERSEY. May 14, 2022. The Lupus Research Alliance (LRA) brought together thousands of people to MetLife Stadium for the 2022 New Jersey Walk with Us to Cure Lupus to raise lupus awareness. The MetLife walk marked the 20th anniversary of the LRA’s national Walk Program. As Honorary Chair of […] READ MORE
March 15, 2022 Each year, Congress must allocate funds for the following year’s budget, and every year, we lead the advocacy effort for the additional funding needed for lupus research to produce better treatments and eliminate racial disparities in healthcare. Last March lupus advocates joined the LRA to submit formal Congressional Asks for Fiscal Year […] READ MORE
May 10, 2022 The Lupus Research Alliance (LRA) and our clinical affiliate Lupus Therapeutics proudly share that one of our distinguished awardees and world-renowned lupus researcher Betty Diamond, MD was elected into the National Academy of Sciences. Dr. Diamond was recognized by the Academy for her breakthrough achievements in molecular medicine and original research. Dr. […] READ MORE
May 5, 2022 Our team for the 2022 TCS New York City Marathon is already up and running with every spot filled and many more on a wait list. In just a few weeks, they have already raised more than $20,000 and they’ve only just begun. Since the Lupus Research Alliance formed Team Life Without […] READ MORE
SUMMIT, N.J., May 2, 2022 /PRNewswire/ — Kicking off Lupus Awareness Month, former Super Bowl Champion and Mad Dog Sports radio personality Willie Colon hosted today the 8th Annual Willie Colon Golf Outing crafted by Tito’s Handmade Vodka for the Lupus Research Alliance (LRA). Mr. Colon is an active member of the Lupus Research Alliance Board […] READ MORE
May 1, 2022 Dear Margy, The lupus community has always been strong, supportive, and ready for any and every challenge. It’s that spirit and unwavering support that drives us to pursue more treatments and aim for a cure. Thanks to you, we have been able to fund some of the biggest breakthroughs in lupus, including […] READ MORE
April 21, 2022 The Lupus Research Alliance is proud to share new results published in the prestigious Journal of Clinical Rheumatology from the data collected for the Lupus Patient-Focused Drug Development (PFDD) Initiative that will add to our understanding of who participates in clinical trials and why. This analysis will help inform development of programs […] READ MORE
April 11, 2022 Please join the Lupus Research Alliance in asking your legislator in the U.S. House of Representatives to sign the “Dear Colleague” letter circulated by leaders of the Congressional Lupus Caucus. Any member of the House can sign onto this letter to show their support for funding federal lupus research programs. This letter […] READ MORE
April 6, 2022 The World Health Organization (WHO) designated today as World Health Day to focus global attention on threats to everyone’s health. The COVID-19 pandemic has been such a threat and continues to endanger the health of those who are immunocompromised from disease or medical treatments such as people with lupus. To observe the […] READ MORE
